BioCentury
ARTICLE | Financial News

Alnylam, Keryx propose follow-ons

January 21, 2015 4:58 AM UTC

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) each revealed plans for follow-on offerings on Tuesday.

Alnylam proposed to raise $450 million in a follow-on underwritten by JPMorgan and Deutsche Bank. Alnylam said it will also conduct a concurrent private placement in which the Genzyme Corp. unit of Sanofi (Euronext:SAN; NYSE:SNY) will purchase enough shares at the public offering price to maintain its 12% ownership of Alnylam. ...